VitaNova Life Sciences (VNOV) Free Cash Flow Growth (1y) (2018 - 2026)
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Free Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 2.41% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | -13.33% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 8.94% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 160.42% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | -34.95% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | -62.28% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | -15.15% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 268.52% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | -2.15% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | -97.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -10.61% |
| Jan 31, 2026 | -143.27% |
| Oct 31, 2025 | 2,327.64% |
| Jul 31, 2025 | 152.34% |
| Apr 30, 2025 | 350.61% |
| Jan 31, 2025 | 238.74% |
| Oct 31, 2024 | 209.62% |
| Jul 31, 2024 | -1,827.57% |
| Apr 30, 2024 | -8,266.96% |
| Jan 31, 2024 | -434.33% |
| Oct 31, 2023 | -250.60% |
| Jul 31, 2023 | -485.59% |
| Apr 30, 2023 | 83.48% |
| Jan 31, 2023 | -637.52% |
| Oct 31, 2022 | -72.92% |
| Jul 31, 2022 | 197.68% |
| Jan 31, 2022 | 144.75% |
| Oct 31, 2021 | 164.09% |
| Jan 31, 2021 | -62.37% |
| Oct 31, 2020 | -161.67% |